Physician profile

Carmen E Rodriguez

Occupational Health (Nurse Practitioner) · Bismarck, ND

NPI 1417045295

$678.03

in general payments reported to CMS, 2019-2025

8 companies · $15.57 in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$539.69

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $336.17 2022-2024 Evenity, Prolia
Radius Health, INC. $195.79 2022-2024 Tymlos
Boston Scientific Corporation $40.84 2024
Alexion Pharmaceuticals, INC. $27.22 2023 Strensiq
Ferring Pharmaceuticals INC. $24.39 2023 Euflexxa
Csl Behring $22.28 2022
Becton, Dickinson and Company $15.77 2024
Vertex Pharmaceuticals Incorporated $15.57 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Carmen E Rodriguez

$678.03

in general payments reported 2019-2025

Years
2022-2025
Top company
Amgen INC.

https://glasscript.com/doctor/11245636/carmen-e-rodriguez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.